| Fund ID | 805-1722724653 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 66% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 23% |
| Fund | Type | Gross assets |
|---|---|---|
| Sv Life Sciences Fund IV Cf, L.P. | Venture Capital | $412.1M |
| Sv Life Sciences Fund VI, L.P. | Venture Capital | $224.7M |
| Sv Life Sciences Fund V, L.P. | Venture Capital | $138.5M |
International Life Sciences Fund III Co-Investment, L.P. reports $563,876 in gross assets, among the top 96% of private funds by size.
The stated minimum investment is $10,000.
International Life Sciences Fund III Co-Investment, L.P. is managed by Sv Health Investors, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.